From 200 Antibody Variants to One Winning Candidate: How Sartorius Is Accelerating Biologics Development

Artificial intelligence is reshaping biologics development by enabling faster antibody selection, early identification o...

October 21, 2026 | Wednesday | Opinion
Mubadala Bio inks strategic partnership with Marcyrl Group to localise broad portfolio of women’s health in UAE

Mubadala Bio has signed a strategic partnership with Marcyrl Pharmaceutical Industries (Marcyrl Group) to localise a bro...

October 22, 2026 | Thursday | News
Korea's NeuroXT receives US FDA 510(k) clearance for AI software supporting prognostic assessment in Mild Cognitive Impairment

South Korea-based startup NeuroXT Inc., a medical device manufacturer, has announced that NEXT-Cue, its AI-based Softwar...

October 21, 2026 | Wednesday | News
China's startup Metis TechBio strikes drug-delivery deal worth $1.1 B with Eli Lilly

METiS TechBio, the innovator in AI-powered drug delivery, has announced a strategic collaboration with US-based Eli Lill...

October 21, 2026 | Wednesday | News
Japan's Toho Holdings invests in biotech startup AdipoSeeds

Japan-based TOHO HOLDINGS has invested in AdipoSeeds, Inc., a venture company spun off from Keio University School of Me...

October 21, 2026 | Wednesday | News
Nxera Pharma Japan licenses Quviviq to Taiwan’s Synmosa Biopharma in 8 APAC markets

Nxera Pharma has announced that its subsidiary, Nxera Pharma Japan has entered into an exclusive license, supply and com...

October 19, 2026 | Monday | News
Taiwan's Jyong Biotech to establish new manufacturing facility and US operations centre in Texas

Jyong Biotech, a Taiwan-based science-driven biotechnology company dedicated to the development and commercialisation of...

October 17, 2026 | Saturday | News
Merck inaugurates State-of-the-Art ADVANCE Bioanalytical Facility in US

Merck, known as MSD outside of the United States and Canada, has inaugurated its state-of-the-art ADVANCE research facil...

October 19, 2026 | Monday | News
AtomVie inks strategic partnership with Jubilant Radiopharma to strengthen logistics and distribution in Clinical Trials

AtomVie Global Radiopharma, a global contract developer and manufacturer (CDMO) for radiopharmaceuticals, has announced ...

October 16, 2026 | Friday | News
Charles River collaborates with Magellan Stem Cells to advance regenerative medicine development

Charles River Laboratories International, Inc. and Magellan Stem Cells, a private Australian biotech and cell-therapy fi...

October 16, 2026 | Friday | News
China's Brii Biosciences unveils BRiSC™, an siRNA Therapeutics discovery platform

Brii Biosciences, a China-based biotechnology company developing therapies to improve patient health and choice across d...

October 16, 2026 | Friday | News
Japan's JCR Pharma receives marketing authorisation in Kuwait for Enzyme Replacement Therapy to treat Hunter Syndrome

Japan-based JCR Pharmaceuticals Co., a global specialty biopharmaceutical company dedicated to developing therapies...

October 15, 2026 | Thursday | News
The Future of FTIR Microscopy Lies in Smarter, Faster and More Precise Chemical Analysis

As laboratories across Asia-Pacific face growing demands for faster, more precise and reproducible analytical testing, F...

October 15, 2026 | Thursday | Opinion
Swiss firm Alentis Therapeutics partners with Korea's PinotBio to develop next-gen ADCs targeting claudin-1

Swiss firm Alentis Therapeutics and South Korea based PinotBio have entered into a research collaboration and licensing ...

October 15, 2026 | Thursday | News
New Sydney laboratory expands 360biolabs’ Australian network

360biolabs, a BioAgilytix company, has opened a new laboratory in Sydney, bringing its established bioanalytical experti...

October 15, 2026 | Thursday | News
Beyond Patent Expiry: Rethinking the Future of Mature Medicines in Asia-Pacific

As pharmaceutical innovation accelerates, mature medicines remain essential to healthcare systems, y...

October 14, 2026 | Wednesday | Opinion
Waters launches AI Link for advancing AI-enabled LC-MS workflows from research to release

US-based Waters Corporation has launched Waters AI Link, a software capability that brings Anthropic's Model Context Pro...

October 14, 2026 | Wednesday | News
Asieris Pharma partners with Theramex for global development of non-surgical treatment for cervical precancerous lesions in ANZ

Theramex, a London-headquartered specialty pharmaceutical company dedicated to women and their health, and China-based A...

October 13, 2026 | Tuesday | News
Roche inks $1.06 B deal with China's Rona Therapeutics for RNA-based metabolic therapies

Chinese startup Rona Therapeutics has granted Roche an exclusive worldwide license for Rona's investigational RNAi candi...

October 14, 2026 | Wednesday | News
Korea's NTL HEALTHCARE announces global launch of On-Premises AI Solution 'CerviCARE® AI AT'

South Korea-based NTL HEALTHCARE, a women's health AI company, has announced the global launch of CerviCARE® AI AT, ...

October 16, 2026 | Friday | News
Americhem opens new clean compounding facility in Suzhou, China

Americhem, a global leader in custom polymer solutions, recently celebrated the opening of its new clean compounding fac...

October 13, 2026 | Tuesday | News
ITOCHU Corp signs capital alliance agreement with MOLCURE Inc. for AI-based drug discovery in Japan

ITOCHU Corporation has signed a capital alliance agreement with MOLCURE Inc., which possesses AI-driven drug discovery t...

October 14, 2026 | Wednesday | News
Australia's Firebrick Pharma secures $732k in strategic investments

Australia-based Firebrick Pharma has secured firm commitments from strategic investors for approximately $732k, through ...

October 12, 2026 | Monday | News
Ono Pharma inks $100 M agreement with Biohaven to develop and commercialise IgG degraders in Japan, South Korea, Taiwan, and ASEAN countries

Japan-based Ono Pharmaceutical has entered into an exclusive license agreement with Biohaven, together with its wholly o...

October 12, 2026 | Monday | News
Korea's Lunit collaborates with US-based Discovery Life Sciences to expand AI-powered tissue analysis for biopharma research

South Korea-based Lunit, a leading provider of AI for cancer diagnostics and precision oncology, has announced a strateg...

October 12, 2026 | Monday | News